Glenmark Pharmaceuticals on Tuesday said it will undertake a new study to test the combined efficacy of two antiviral drugs, Favipiravir and Umifenovir, as a potential Covid-19 treatment regimen. The two antiviral drugs have a different mechanism of action, and their combination may demonstrate improved treatment efficacy by effectively tackling high viral loads.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3d4qzyq
